During the past decade, Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie" are "Non-small Cell Lung Cancer (NSCLC)" (1 trials) and "Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie" in a lesser frequency.

Most popular intervention types in "Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (anti-PD-L1) antibody" (1 trials), "Carboplatin" (1 trials), "Durvalumab" (1 trials) and "Nab-Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".